Nazanin Anaraki

Nazanin Anaraki

Auto-generated profile, based on publicly available information

Nazanin Anaraki

Tehran University of Medical Sciences

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2025 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
PDParham Dastjerdi
Parham Dastjerdi
NMNegin Sadat Hosseini Mohammadi
Negin Sadat Hosseini Mohammadi
NANazanin Anaraki
Nazanin Anaraki
SRSoheil Rahmati
Soheil Rahmati
RNReza Nikfar
Reza Nikfar
HSHamidreza Soleimani
Hamidreza Soleimani
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in individuals with type 1 diabetes mellitus (T1DM), with insulin resistance (IR) increasingly recognized as a key contributor. The estimated glucose disposal rate (eGDR), a surrogate marker of insulin sensitivity, has been proposed as a predictor of adverse cardiovascular outcomes in T1DM. This systematic review and meta-analysis aimed to assess the association between eGDR and adverse cardiovascular outcomes. A systematic search of PubMed, Embase, Scopus, and Cochrane Library was conducted through March 6, 2025, to identify studies reporting multivariable-adjusted risk estimates linking eGDR with cardiovascular outcomes in individuals with T1DM. Pooled hazard ratios (HRs) were estimated using random-effects models with the Paule–Mandel method and Knapp–Hartung adjustment. Subgroup and meta-regression analyses were conducted to explore potential effect modifiers, and leave-one-out (LOO) sensitivity analyses were performed to assess the robustness of findings. Sixteen studies comprising 29,075 individuals with T1DM were included. Higher eGDR was significantly associated with lower risk of MACE and all-cause mortality, with hazard ratios per unit increase of 0.79 (95% CI: 0.72–0.87; I² = 63%) and 0.84 (95% CI: 0.82–0.86; I² = 0%), respectively. Lower eGDR was also associated with increased risk of CAD (low vs. high eGDR: HR 3.61; 95% CI: 2.83–4.62; I² = 0%). Subgroup analyses suggested a stronger protective association between eGDR and MACE among older individuals (≥ 40 years), those with BMI < 25 kg/m², and those with longer diabetes duration (≥ 20 years). LOO sensitivity analyses showed that CAD was the only outcome influenced by exclusion of the largest study. Lower eGDR is consistently associated with increased risk of MACE, CAD, and all-cause mortality in individuals with T1DM. These findings support the utility of eGDR as a practical, non-invasive marker for cardiovascular risk stratification in this high-risk population.

4 June 2025 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
AMArman Soltani Moghadam
Arman Soltani Moghadam
NKNasim Kakavand
Nasim Kakavand
FSFatemeh Ojaghi Shirmard
Fatemeh Ojaghi Shirmard
APAmirhossein Poopak
Amirhossein Poopak
NANazanin Anaraki
Nazanin Anaraki
KHKaveh Hosseini
Kaveh Hosseini

25 May 2025 in Innovative Journal of Pediatrics
Verified
Journal Article
Open access
NANazanin Anaraki
Nazanin Anaraki
KSKamran Shirbache
Kamran Shirbache
Ana PresedoAna Presedo
Ana Presedo
ANAhmadreza Nezameslami
Ahmadreza Nezameslami
MNMohammad Hossein Nabian
Mohammad Hossein Nabian
Context: Congenital idiopathic clubfoot is a significant musculoskeletal deformity affecting children globally. It is characterized by hindfoot varus, midfoot cavus, forefoot adduction, and ankle equinus. The Ponseti method has proven to be highly effective and is now the gold standard for treatment. However, long-term follow-up studies indicate a variable relapse rate. Timely diagnosis of relapse is crucial, underscoring the importance of regular follow-up visits. Poor compliance with brace wear is a primary cause of relapse; therefore, educating families on proper adherence to the treatment regimen is essential. This review article discusses the anatomy, etiology, various treatment approaches, and strategies for managing relapses in clubfoot. Evidence Acquisition: The Ponseti method has proven to be highly effective and is now the gold standard for treatment. However, long-term follow-up studies indicate a variable relapse rate. Results: Timely diagnosis of relapse is crucial, underscoring the importance of regular follow-up visits. Poor compliance with brace wear is a primary cause of relapse. Conclusions: Educating families on proper adherence to the treatment regimen is essential. This review article discusses the anatomy, etiology, various treatment approaches, and strategies for managing relapses in clubfoot.

1 January 2026 in Case Reports in Surgery
Verified
Journal Article
Open access
MBMohamad Behzadi
Mohamad Behzadi
NANazanin Anaraki
Nazanin Anaraki
JSJavad Salimi
Javad Salimi
Teratomas are germ cell tumors, with ovarian teratomas being the most common type. However, extragonadal teratomas are extremely rare. Omental teratomas are the most common type of extragonadal teratomas. Most patients with omental teratomas are asymptomatic, making preoperative diagnosis challenging. Imaging studies, such as CT scans, can provide valuable information, but a definitive diagnosis requires histopathological examination. In this case, a 65‐year‐old Iranian woman presented with mild abdominal pain and a normal physical examination. A preoperative abdominopelvic CT scan revealed a calcified pelvic mass with fat components, suggesting a connection to the right fallopian tube. However, during surgery, the mass was found to be in the greater omentum, with no adnexal involvement. Histopathological examination confirmed a mature teratoma. Treatment for mature teratomas typically involves surgical excision, which was successfully performed in this case, resulting in a smooth postoperative recovery.

19 June 2026 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDParham Dastjerdi
Parham Dastjerdi
KTKiarash Tavakoli
Kiarash Tavakoli
RNRoozbeh Narimani-Javid
Roozbeh Narimani-Javid
NANazanin Anaraki
Nazanin Anaraki
HSHedieh Shayesteh
Hedieh Shayesteh
HSHamidreza Soleimani
Hamidreza Soleimani
Functional mitral regurgitation (FMR) carries poor prognosis, and optimal management remains debated. Mitral Transcatheter Edge-to-Edge Repair (MTEER) is an alternative to surgical repair (SMVR) or optimized medical therapy (OMT), but long-term outcomes are uncertain. PubMed, Embase, Scopus, and the Cochrane Library were searched for studies reporting Kaplan-Meier curves of MTEER, SMVR, or OMT in FMR. Individual patient data (IPD) were reconstructed using the Liu method with accuracy checks. Pooled IPD were analyzed with Cox and time-varying Cox models, landmark, time-restricted, and restricted mean survival time analyses. Sixteen studies (n = 4,570) were included. Patients undergoing MTEER were older and higher risk, with greater prevalence of atrial fibrillation, prior myocardial infarction, chronic kidney disease, higher EuroSCORE, and more frequent NYHA class ≥ III compared with SMVR. Over up to 60 months, both MTEER (HR: 0.65; 95% CI: 0.57-0.75; p < 0.001) and SMVR (HR: 0.39; 95% CI: 0.33-0.46; p < 0.001) significantly reduced all-cause mortality versus OMT, whereas MTEER carried higher mortality risk than SMVR (HR: 1.68; 95% CI: 1.43-1.97; p < 0.001). MTEER was less effective than SMVR in reducing recurrent MR > 2 (HR: 3.31; 95% CI: 1.62-6.75; p < 0.001) and reoperation (HR: 4.62; 95% CI: 2.22-9.61; p < 0.001). In contrast, MTEER reduced hospitalization risk by 30% compared to OMT (HR: 0.70; 95% CI: 0.64-0.77; p < 0.001) and decreased MACE by 21% (HR: 0.79; 95% CI: 0.73-0.84; p < 0.001). MTEER improves survival and reduces hospitalization and MACE compared with OMT but is less durable than SMVR, with higher risks of recurrent MR, reoperation, and late mortality.

30 October 2026 in Journal of the American Heart Association
Verified
Journal Article
Closed access
MBMohammad‐Mahdi Bastan
Mohammad‐Mahdi Bastan
SSSahand Siami
Sahand Siami
FJFatemeh Jodeiri
Fatemeh Jodeiri
SKSina Kazemian
Sina Kazemian
MEMandana Ebrahimzade
Mandana Ebrahimzade
KHKaveh Hosseini
Kaveh Hosseini
Background: Data on transcatheter aortic valve replacement (TAVR) outcomes in the Middle East and North Africa region are limited. We synthesized available evidence on post‐TAVR clinical outcomes in the Middle East and North Africa region. Methods: We systematically searched PubMed, Embase, and Scopus from inception through May 2025 for studies reporting TAVR outcomes in this region. Outcomes included device success, all‐cause death, cardiovascular death, myocardial infarction, stroke, new‐onset atrial fibrillation, moderate to severe paravalvular leak, and permanent pacemaker implantation. Overall incidence rates were pooled via Poisson analysis and reported per 100 person‐years with 95% CIs. Results: Forty‐eight studies encompassing 7331 patients (mean age, 76.9±8.5 years; 52.4% women) were included. Pooled device success rate was 96.4% (95% CI, 95.8%–97.0%). At latest follow‐up, pooled incidence rates per 100 person‐years were 13.7 for all‐cause death (95% CI, 12.9–14.6), 4.8 for cardiovascular death (95% CI, 4.1–5.7), 1.0 for myocardial infarction (95% CI, 0.7–1.4), 1.6 for stroke (95% CI, 1.3–1.9), 2.7 for moderate to severe paravalvular leak (95% CI, 2.2–3.4), 6.5 for new‐onset atrial fibrillation (95% CI, 5.5–7.7), and 10.0 for permanent pacemaker implantation (95% CI, 9.2–10.9). Post hoc exploratory meta‐regression identified significant study‐level modifying effects, with higher mean age and greater use of first‐generation versus second‐generation valves associated with higher overall all‐cause mortality incidence following TAVR. Certainty of evidence was low or very low across all outcomes. Conclusions: TAVR in the Middle East and North Africa region was associated with high device success rate and relatively low cardiovascular death. Permanent pacemaker implantation was the most prevalent post‐TAVR complication. Further studies are warranted to optimize TAVR practice in this region.